Health Society Insights on Cannabis and Stroke Risk
Cannabis stroke risk is an important consideration in clinical practice. Emerging data highlight the need to differentiate therapeutic cannabis use from recreational use regarding stroke risk. Patients should discuss individual risk factors and treatment…
Daily Digest: Cannabis and Stroke Risk in Focus as Texas Expands Access — March 09, 2026
This digest highlights cannabis and stroke risk with new research emphasizing cardiovascular concerns. Texas expands medical cannabis access, reflecting growing infrastructure. Edible cannabis pharmacokinetics also receive attention in this update.
Cocaine and Cannabis Use Elevates Stroke Risk Significantly
Cocaine cannabis stroke risk significantly increases the likelihood of strokes, especially in younger patients. Clinicians should assess substance use patterns to identify modifiable risk factors. Counseling about stroke risk is essential for patients…
Recreational Drugs and Stroke Risk: Clinical Evidence on Cannabis
Cannabis stroke risk clinical evidence indicates a 37% increased risk of stroke among users. This finding is critical for stroke prevention strategies, especially in younger populations. Clinicians should integrate cannabis use screening into…
Study highlights stroke risk linked to recreational drugs, including among young users
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchSafetyMental Health Why This Matters Clinicians need to recognize cannabis as a modifiable stroke…
Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026
A synthesis of 12 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Recreational Drugs Triple Stroke Risk in Young People, Study Finds
A recent study highlights recreational drugs stroke risk as tripling in young adults. Cannabis and cocaine use significantly elevate stroke risk in this population. Clinicians should screen for recreational drugs stroke risk when assessing young stroke…
Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026
This digest highlights cannabinoid drug delivery breakthroughs alongside key findings on liver disease and adolescent brain health. Advances in delivery technology improve cannabinoid bioavailability and therapeutic potential. Clinicians should consider…
New study reveals surprising benefit of GLP-1s beyond weight loss
A recent study highlights the potential of GLP-1 addiction risk reduction in lowering vulnerability to multiple substances. This research suggests GLP-1 receptor agonists may influence reward pathways independently of weight loss. Clinicians should…
Youth and Cannabis: Understanding the Risks to the Adolescent Brain
Cannabis use adolescent brain risks are a growing concern as legalization expands. Clinicians face challenges counseling youth due to variable product potency and incomplete data. Understanding these risks is crucial for adolescent health and safety.